Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
Kyle L O’Donnell, Andrea Marzi Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USACorrespondence: Andrea Marzi Email marzia@niaid.nih.govAbstract: Ebola virus disease (EVD) remains...
Main Authors: | O'Donnell KL, Marzi A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-03-01
|
Series: | Biologics: Targets & Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/immunotherapeutics-for-ebola-virus-disease-hope-on-the-horizon-peer-reviewed-article-BTT |
Similar Items
-
Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application
by: Alexander Hargreaves, et al.
Published: (2021-09-01) -
Editorial: Antibody Therapeutics for the Treatment of Filoviral Infection
by: Charles D. Murin, et al.
Published: (2022-02-01) -
Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines
by: Taniguchi Satoshi, et al.
Published: (2012-10-01) -
Modeling of the Ebola Virus Delta Peptide Reveals a Potential Lytic Sequence Motif
by: William R. Gallaher, et al.
Published: (2015-01-01) -
Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection
by: Olivier Tshiani Mbaya, et al.
Published: (2021-08-01)